Stock Ticker

  • Loading stock data...

The Virus Testing Stocks Pullback Opportunity (CODX, FLGT, ALST, LH)

The world exploded with a cheer of joy on Monday of this week as Pfizer put out extremely encouraging news about its top coronavirus vaccine candidate, noting that it registered a 90% efficacy rate with no complications in its phase 3 study involving over 43K patients. Stocks took flight, bonds dropped, and small-caps and cyclicals […]

Johnson & Johnson (NYSE:JNJ) Coronavirus Vaccine To Start Late-Stage Trial In September

A coronavirus vaccine being developed by Johnson & Johnson (NYSE:JNJ) is expected to move to late-stage trial in September. In an announcement last week, the company said the phase three study will enroll 60,000 candidates aged 18 and above in around 180 locations in the U.S and abroad. Details released by the company indicate that […]

Major Drug Makers; Johnson & Johnson (JNJ) and Eli Lilly (LLY) Database Collaboration – JNJ, PFE, BMY, MRK, ABT

On Monday, current three major drug makers Eli Lilly & Co. (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), and Merck & Co., Inc. (NYSE:MRK) have decided to collaborate on a database that will assist speed up the investigational drug testing process. The firm will each contribute to a database, which will be made of doctors, hospitals and […]

Quest Diagnostics (NYSE:DGX) Announce Quarter Dividend and Cost Cut Plan – DGX, DVAX, PFE, JNJ, BMY

Quest Diagnostics Inc (NYSE:DGX) announced on Friday that it is surging its quarterly dividend by 76 percent to 30 cents per share. It will be paid on Jan. 28. The firm reported that it aims to cut costs by $500M in 2014. It will go out 2014 with a run-rate savings of $600M, increase from […]